AMPK Phosphorylation Modulates Pain by Activation of NLRP3 Inflammasome

Antioxidants and Redox Signaling

Volumn 24, Issue 3, 2016, Pages 157-170

  Bullón, Pedro ^a   Alcocer Gómez, Elísabet ^a,b   Carrión, Angel M ^b   Marín Aguilar, Fabiola ^a   Garrido Maraver, Juan ^b   Román Malo, Lourdes ^a   Ruiz Cabello, Jesus ^c   Culic, Ognjen ^d   Ryffel, Bernhard ^e   Apetoh, Lionel ^f,g,h   Ghiringhelli, François ^f,g,h   Battino, Maurizio ⁱ   Sánchez Alcazar, José Antonio ^b   Cordero, Mario D ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d UNIVERSITY OF ZAGREB   (Croatia)

^e Molecular Immunology   (France)

^f Chu   (France)

^g CENTRE GEORGES FRANÇOIS LECLERC   (France)

^h UNIVERSITÉ DE BOURGOGNE   (France)

ⁱ UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; METFORMIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; SUNITINIB; CARRIER PROTEIN; CRYOPYRIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INDOLE DERIVATIVE; NLRP3 PROTEIN, MOUSE; PYRROLE DERIVATIVE;

ADULT; AGE; ANIMAL EXPERIMENT; ARTICLE; BLOOD CELL; BODY FAT; BODY MASS; BODY WEIGHT; BONE MASS; CALORIC RESTRICTION; CHRONIC PAIN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FATIGUE; FEMALE; FIBROMYALGIA; GENE INACTIVATION; HUMAN; HUMAN CELL; HYPERALGESIA; INTRAABDOMINAL FAT; KNOCKOUT MOUSE; MALE; MOLECULAR MECHANICS; MOUSE; MUSCLE MASS; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; PULSE RATE; SLEEP DISORDER; SYSTOLIC BLOOD PRESSURE; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BLOOD; DRUG EFFECTS; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION;

ADULT; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CARRIER PROTEINS; FEMALE; FIBROMYALGIA; HUMANS; INDOLES; INFLAMMASOMES; INTERLEUKIN-18; INTERLEUKIN-1BETA; MALE; METFORMIN; MICE; MIDDLE AGED; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; PAIN; PAIN PERCEPTION; PHOSPHORYLATION; PYRROLES;

EID: 84955243435     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.6120     Document Type: Article

References (31)

1. Bagis S, Tamer L, Sahin G, et al. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder Rheumatol Int 25: 188-190, 2005.
2. Baroja-Mazo A, Martn-Sánchez F, Gomez AI, Martnez CM, Amores-Iniesta J, Compan V, Barberà-Cremades M, Yaguë J, Ruiz-Ortiz E, Antón J, Buján S, Couillin I, Brough D, Arostegui JI, Pelegŕn P. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol 15: 738-748, 2014.
3. Bazzichi L, Giannaccini G, Betti L, Fabbrini L, Schmid L, Palego L, Giacomelli C, Rossi A, Giusti L, De Feo F, Giuliano T, Mascia G, Bombardieri S, Lucacchini A. ATP, calcium and magnesium levels in platelets of patients with primary fibromyalgia. Clin Biochem 41: 1084-1090, 2008.
4. Colombo SL and Moncada S. AMPKalpha1 regulates the antioxidant status of vascular endothelial cells. Biochem J 421: 163-169, 2009.
5. Cordero MD, Alcocer-Gómez E, Culic O, Carrión AM, de Miguel M, Dáz-Parrado E, Pérez-Villegas EM, Bullón P, Battino M, Sánchez-Alcazar JA. NLRP3 inflammasome is activated in fibromyalgia: the effect of coenzyme Q10. Antioxid Redox Signal 20: 1169-1180, 2014.
6. Cordero MD, De Miguel M, Moreno Fernández AM, Carmona López IM, Garrido Maraver J, Cotán D, Gómez Izquierdo L, Bonal P, Campa F, Bullon P, Navas P, Sánchez Alcázar JA. Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implication in the pathogenesis of the disease. Arthritis Res Ther 12: R17, 2010.
7. de los Santos-Arteaga M, Sierra-Domnguez SA, Fontanella GH, Delgado-Garcá JM, Carrión AM. Analgesia induced by dietary restriction is mediated by the kappaopioid system. J Neurosci 23: 11120-11126, 2003.
8. Fontana L. Neuroendocrine factors in the regulation of inflammation: excessive adiposity and calorie restriction. Exp Gerontol 44: 41-45, 2009.
9. Gerdle B, Forsgren MF, Bengtsson A, Leinhard OD, Sören B, Karlsson A, Brandejsky V, Lund E, Lundberg P. Decreased muscle concentrations of ATP and PCR in the quadriceps muscle of fibromyalgia patients-a 31P-MRS study. Eur J Pain 17: 1205-1215, 2013.
10. Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 13: 251-262, 2012.
11. Kuner R. Central mechanisms of pathological pain. Nat Med 16: 1258-1266, 2010.
12. Labuzek K, Liber S, Suchy D, Okopiea° BA. A successful case of pain management using metformin in a patient with adiposis dolorosa. Int J Clin Pharmacol Ther 51: 517-524, 2013.
13. Laderoute KR, Calaoagan JM, Madrid PB, Klon AE, Ehrlich PJ. SU11248 (sunitinib) directly inhibits the activity of mammalian 5'-AMP-activated protein kinase (AMPK). Cancer Biol Ther 10: 68-76, 2010.
14. Lawlor KE and Vince JE. Ambiguities in NLRP3 inflammasome regulation: is there a role for mitochondria Biochim Biophys Acta 1840: 1433-1440, 2014.
15. Li Q, Tian Y, Wang ZF, Liu SB, Mi WL, Ma HJ, Wu GC, Wang J, Yu J, Wang YQ. Involvement of the spinal NALP1 inflammasome in neuropathic pain and aspirintriggered-15-epi-lipoxin A4 induced analgesia. Neuroscience 254: 230-240, 2013.
16. Li WW, Guo TZ, Liang D, Shi X, Wei T, Kingery WS, Clark JD. The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome. Pain 147: 277-286, 2009.
17. Lopes AH, Talbot J, Silva RL, Lima JB, Franca RO, VErri WA Jr, Mascarenhas DP, Ryffel B, Cunha FQ, Zamboni DS, Cunha TM. Peripheral NLCR4 inflammasome participates in the genesis of acute inflammatory pain. Pain 156: 451-459, 2015.
18. Marchetti C, Chojnacki J, Toldo S, Mezzaroma E, Tranchida N, Rose SW, Federici M, Van Tassell BW, Zhang S, Abbate A. A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse. J Cardiovasc Pharmacol 63: 316-322, 2014.
19. Martin-Montalvo A, Mercken EM, Mitchell SJ, Palacios HH, Mote PL, Scheibye-Knudsen M, Gomes AP, Ward TM, Minor RK, Blouin MJ, Schwab M, Pollak M, Zhang Y, Yu Y, Becker KG, Bohr VA, Ingram DK, Sinclair DA, Wolf NS, Spindler SR, Bernier M, de Cabo R. Metformin improves healthspan and lifespan in mice. Nat Commun 4: 2192, 2013.
20. Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241, 2006.
21. Melemedjian OK, Asiedu MN, Tillu DV, Sanoja R, Yan J, Lark A, Khoutorsky A, Johnson J, Peebles KA, Lepow T, Sonenberg N, Dussor G, Price TJ. Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain. Mol Pain 7: 70, 2011.
22. O'Neill LA and Hardie DG. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493: 346-355, 2013.
23. Price TJ and Dussor G. AMPK: an emerging target for modification of injury-induced pain plasticity. Neurosci Lett 557 Pt A: 9-18, 2013.
24. Rodgers MA, Bowman JW, Liang Q, Jung JU. Regulation where autophagy intersects the inflammasome. Antioxid Redox Signal 20: 495-506, 2014.
25. Russel OQ, Möser CV, Kynast KL, King TS, Stephan H, Geisslinger G, Niederberger E. Activation of the AMPactivated protein kinase reduces inflammatory nociception. J Pain 14: 1330-1340, 2013.
26. Schroder K, Zhou R, Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger Science 327: 296-300, 2010.
27. Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, Ramanujan VK, Wolf AJ, Vergnes L, Ojcius DM, Rentsendorj A, Vargas M, Guerrero C, Wang Y, Fitzgerald KA, Underhill DM, Town T, Arditi M. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36: 401-414, 2012.
28. Steinberg GR and Schertzer JD. AMPK promotes macrophage fatty acid oxidative metabolism to mitigate inflammation: implications for diabetes and cardiovascular disease. Immunol Cell Biol 92: 340-345, 2014.
29. Tillu DV, Melemedjian OK, Asiedu MN, Qu N, De Felice M, Dussor G, Price TJ. Resveratrol engages AMPK to attenuate ERK and mTOR signaling in sensory neurons and inhibits incision-induced acute and chronic pain. Mol Pain 8: 5, 2012.
30. Viollet B and Andreelli F. AMP-activated protein kinase and metabolic control. Handb Exp Pharmacol 203: 303-330, 2011.
31. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469: 221-225, 2011.